Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 54 results.

Pages

Filtering by content type: Press Release

The Federal Trade Commission charged a California-based company called Golden Sunrise Nutraceutical, Inc. with deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, the disease caused by coronavirus.
The Federal Trade Commission is mailing 22,581 refund checks totaling more than $470,000 to consumers nationwide who bought two deceptively marketed health products—TrueAloe and AloeCran, from a company called NatureCity, LLC.
The Federal Trade Commission is mailing 143,636 refund checks totaling more than $8.5 million to consumers who bought three dietary supplements deceptively marketed by National Urological Group, Inc. (NUG) and several related companies.
A Florida-based company that has promoted its Isoprex supplement to older adults as a miracle cure for pain and joint inflammation has agreed to a settlement with the Federal Trade Commission that bars the company from continuing to make its unproven claims.
The Federal Trade Commission and the U.S. Department of Justice Antitrust Division today issued joint statement detailing an expedited antitrust procedure and providing guidance for collaborations of businesses working to protect the health and safety of Americans during the COVID-19 pandemic.
Nevada-based Health Center, Inc. (HCI) and its owner Peggy Pearce agreed to halt their allegedly deceptive advertising claims about three “cure-all” health and wellness products that targeted older consumers nationwide, pursuant to a settlement with the Federal Trade Commission. The stipulated...
The Federal Trade Commission and U.S. Food and Drug Administration (FDA) have sent warning letters to seven companies allegedly selling unapproved products that may violate federal law by making deceptive or scientifically unsupported claims about their ability to treat coronavirus (COVID-19). The...
Under a settlement with the Federal Trade Commission, the marketers of an electrical nerve stimulation device called Quell have agreed to pay at least $4 million and stop making deceptive claims that the device treats pain throughout the body when placed below the knee and is clinically proven and...
The Federal Trade Commission is mailing 27,174 refund checks totaling over $551,000 to consumers who purchased deceptively marketed “cognitive improvement” supplements.
The Federal Trade Commission sued two companies to stop them from continuing to deceive consumers with false claims that their pills are scientifically proven to alleviate joint pain by growing new bone and cartilage.
The sellers of a pill called ReJuvenation settled Federal Trade Commission charges that they deceptively claimed that their product is a virtual cure-all for age-related ailments—including cell damage, heart attack damage, brain damage, blindness, and deafness—and even aging itself.The orders...
A Latvian payment processor and its former CEO have agreed to settle the Federal Trade Commission’s complaint against them. The complaint alleges that they engaged in unlawful conduct that enabled a deceptive “free trial” offer scheme by U.S.-based defendants. “Transact Pro helped scammers drain...
The marketers of a dietary supplement called Synovia agreed to settle Federal Trade Commission charges by halting the deceptive tactics they allegedly used to mislead consumers into thinking Synovia could treat arthritis and alleviate joint pain.
The Federal Trade Commission announced a joint warning letter issued with the U.S. Food and Drug Administration (FDA) to Rooted Apothecary, LLC for selling products containing cannabidiol (CBD) online with potentially unsubstantiated claims that the products can treat autism, attention-deficit/...
The operators of a deceptive negative option scheme have agreed to a court-ordered preliminary injunction temporarily barring them from a wide range of conduct. The preliminary injunction stops the defendants from misleading consumers about supposedly “free trial” offers, enrolling them in unwanted...
The Federal Trade Commission is mailing 2,897 checks totaling more than $113,000 to fully refund consumers who bought FlexiPrin, a deceptively marketed joint pain supplement. The average check amount is $39.18.
Chemical Free Solutions LLC (CFS), the seller of Cedarcide Original, a line of cedar oil-based products deceptively marketed as effective at stopping and preventing bed bug infestations, has settled Federal Trade Commission charges that it violated a 2013 order barring it from making scientifically...
The Federal Trade Commission and the Maine Office of the Attorney General today announced a complaint and three settlements with dietary supplement marketers who allegedly used radio infomercials deceptively formatted as talk shows and print ads featuring fictitious endorsers to advertise...
The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers.
According to the FTC’s complaint, between June 2013 and October 2015 the defendants marketed and sold the “Doctor Trusted” seal and certification program to websites that primarily offered health-related products and services, such as dietary supplements.

Pages